Skip to main content
SpringerLink
Log in

Non-atherosclerotic Cardiac Manifestations of Rheumatoid Arthritis

  • Chapter
  • First Online:
Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis

Abstract

First clearly described by Charcot in the 19th century, pericardial disease has been regarded as the most common cardiac manifestation of rheumatoid arthritis (RA).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med. 1973;54:445-452.

    Google Scholar 

  2. Corrao S, Messina S, Pistone G, Calvo L, Scaglione R, Licata G. Heart involvement in rheumatoid arthritis: Systematic review and meta-analysis. Int J Cardiol. 2013;167:2031-2038.

    Google Scholar 

  3. Hara KS, Ballard DJ, Ilstrup DM, Connolly DC, Vollertsen RS. Rheumatoid pericarditis: clinical features and survival. Medicine (Baltimore). 1990;69920:81-91.

    Google Scholar 

  4. Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford). 2006;45:iv4-iv7.

    Google Scholar 

  5. Jurik AG, Graudal H. Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol Int. 1986;6:37-42.

    Google Scholar 

  6. Nomeir AM, Turner RA, Watts LE. Cardiac involvement in rheumatoid arthritis. Followup study. Arthritis Rheum. 1979;22:561-564.

    Google Scholar 

  7. Barcin C, Yalcinkaya E, Kabul HK. Cholesterol pericarditis associated with rheumatoid arthritis: a rare cause of pericardial effusion. Int J Cardiol. 2013;166:e56-e58.

    Google Scholar 

  8. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986;29:706-714.

    Google Scholar 

  9. Edwards MH, Leak AM. Pericardial effusions on anti-tnf therapy for rheumatoid arthritis–a drug side effect or uncontrolled systemic disease? Rheumatology (Oxford). 2009;48:316-317.

    Google Scholar 

  10. Harney S, O’Shea FD, FitzGerald O. Peptostreptococcal pericarditis complicating anti-tumour necrosis factor alpha treatment in rheumatoid arthritis. Ann Rheum Dis. 2002;61:653-654.

    Google Scholar 

  11. Lutman C, Finocchiaro G, Abate E, Milo M, Morassi P, Sinagra G. Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate. J Cardiovasc Med (Hagerstown). 2014;15912):880-882.

    Google Scholar 

  12. Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis. A systematic review. JAMA. 2015;314:1498-1506.

    Google Scholar 

  13. Jain S, Thongprayoon C, Espinosa RE, et al. Effectiveness and safety of anakinra for management of refractory pericarditis. Am J Cardiol. 2015;116:1277-1279.

    Google Scholar 

  14. Lebowitz WB. The heart in rheumatoid arthritis (rheumatoid disease). A clinical and pathological study of sixty-two cases. Ann Intern Med. 1963;58:102-123.

    Google Scholar 

  15. Bonfiglio T, Atwater EC. Heart disease in patients with seropositive rheumatoid arthritis; a controlled autopsy study and review. Arch Intern Med. 1969;124:714-719.

    Google Scholar 

  16. Abbas A, Byrd BF, 3rd. Right-sided heart failure due to right ventricular cavity obliteration by rheumatoid nodules. Am J Cardiol. 2000;86:711-712.

    Google Scholar 

  17. Mavrogeni S, Sfikakis PP, Karabela G, et al. Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block. Int J Cardiol. 2014;171:82-87.

    Google Scholar 

  18. Guedes C, Bianchi-Fior P, Cormier B, Barthelemy B, Rat AC, Boissier MC. Cardiac manifestations of rheumatoid arthritis: A case-control transesophageal echocardiography study in 30 patients. Arthritis Rheum. 2001;45:129-135.

    Google Scholar 

  19. Steel KE, Kwong RY. Application of cardiac magnetic resonance imaging in cardiomyopathy. Curr Heart Fail Rep. 2008;5:128-135.

    Google Scholar 

  20. Puntmann VO, Taylor PC, Barr A, Schnackenburg B, Jahnke C, Paetsch I. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study. Rheumatology (Oxford). 2010;49:528-535.

    Google Scholar 

  21. Slack JD, Waller B. Acute congestive heart failure due to the arteritis of rheumatoid arthritis: early diagnosis by endomyocardial biopsy: A case report. Angiology. 1986;37:477-482.

    Google Scholar 

  22. Seferovic PM, Ristic AD, Maksimovic R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford). 2006;45:iv39-iv42.

    Google Scholar 

  23. Singh JA, Furst DE, Bharat A, et al. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:625-639.

    Google Scholar 

  24. Joyce E, Fabre A, Mahon N. Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: Key diagnostic features and literature review. Eur Heart J Acute Cardiovasc Care. 2013;2:77-83.

    Google Scholar 

  25. Yogasundaram H, Putko BN, Tien J, et al. Hydroxychloroquine-induced cardiomyopathy: Case report, pathophysiology, diagnosis, and treatment. Can J Cardiol. 2014;30:1706-1715.

    Google Scholar 

  26. Rahman JE, Helou EF, Gelzer-Bell R, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004;43:410-415.

    Google Scholar 

  27. Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol. 2007;50:2101-2110.

    Google Scholar 

  28. Perugini E, Rapezzi C, Piva T, et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart. 2006;92:343-349.

    Google Scholar 

  29. Hattori Y, Ubara Y, Sumida K, et al. Tocilizumab improves cardiac disease in a hemodialysis patient with aa amyloidosis secondary to rheumatoid arthritis. Amyloid. 2012;19:37-40.

    Google Scholar 

  30. Wada Y, Kobayashi D, Murakami S, et al. Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents. Scand J Rheumatol. 2011;40:402-404.

    Google Scholar 

  31. Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36:482-489c.

    Google Scholar 

  32. Hollan I, Meroni PL, Ahearn JM, et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013;12:1004-1015.

    Google Scholar 

  33. Prasad M, Hermann J, Gabriel SE, et al. Cardiorheumatology: Cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015;12:168-176.

    Google Scholar 

  34. Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev. 2014;13:936-944.

    Google Scholar 

  35. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60:2263-2270.

    Google Scholar 

  36. Schnabel RB, Larson MG, Yamamoto JF, et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol. 2009;104:92-96.

    Google Scholar 

  37. Yavuzkir M, Ozturk A, Dagli N, et al. Effect of ongoing inflammation in rheumatoid arthritis on p-wave dispersion. J Int Med Res. 2007;35:796-802.

    Google Scholar 

  38. Turgut O, Tandogan I, Yilmaz MB, Yalta K, Aydin O. Association of p wave duration and dispersion with the risk for atrial fibrillation: practical considerations in the setting of coronary artery disease. Int J Cardiol. 2010;144:322-324.

    Google Scholar 

  39. Lindhardsen J, Ahlehoff O, Gislason GH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ. 2012;344:e1257.

    Google Scholar 

  40. Kim SC, Liu J, Solomon DH. The risk of atrial fibrillation in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73:1091-1095.

    Google Scholar 

  41. Bacani AK, Crowson CS, Roger VL, Gabriel SE, Matteson EL. Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. BioMed Res Internat. 2015;2015:809514.

    Google Scholar 

  42. Jurik AG, Moller P. Atrioventricular conduction time in rheumatoid arthritis. Rheumatol Int. 1985;5:205-207.

    Google Scholar 

  43. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum. 2005;52:402-411.

    Google Scholar 

  44. Chauhan K, Ackerman MJ, Crowson CS, Matteson EL, Gabriel SE. Population-based study of QT interval prolongation in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2015;33:84-89.

    Google Scholar 

  45. Panoulas VF, Toms TE, Douglas KM, et al. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: An association driven by high inflammatory burden. Rheumatology (Oxford). 2014;53:131-137.

    Google Scholar 

  46. Lazzerini PE, Acampa M, Capecchi PL, et al. Association between high sensitivity c-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med. 2013;24:368-374.

    Google Scholar 

  47. Sen D, Gonzalez-Mayda M, Brasington RD Jr. Cardiovascular disease in rheumatoid arthritis. Rheum Dis Clin North Am. 2014;40:27-49.

    Google Scholar 

  48. Kaneko S, Yamashita H, Sugimori Y, et al. Rheumatoid arthritis-associated aortitis: a case report and literature review. Springerplus. 2014;3:509

    Google Scholar 

  49. Yiu KH, Wang S, Mok MY, et al. Relationship between cardiac valvular and arterial calcification in patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 2011;38:621-627.

    Google Scholar 

  50. Maksimowicz-McKinnon K, Mandell BF. Understanding valvular heart disease in patients with systemic autoimmune diseases. Cleve Clin J Med. 2004;71:881-885.

    Google Scholar 

  51. Eiken PW, Edwards WD, Tazelaar HD, McBane RD, Zehr KJ. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. Mayo Clin Proc. 2001;76:1204-1212.

    Google Scholar 

  52. Beckhauser AP, Vallin L, Burkievcz CJ, Perreto S, Silva MB, Skare TL. Valvular involvement in patients with rheumatoid arthritis. Acta Reumatol Port. 2009;34:52-56.

    Google Scholar 

  53. Erdozain JG, Ruiz-Irastorza G, Segura MI, et al. Cardiac valve replacement in patients with antiphospholipid syndrome. Arthritis Care Res(Hoboken). 2012;64:1256-1260.

    Google Scholar 

  54. Vassileva CM, Kwedar K, Boley T, Markwell S, Hazelrigg S. Mitral valve procedure selection and outcomes in patients with rheumatoid arthritis. J Heart Valve Dis. 2013;22:14-19

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic College of Medicine, Rochester, MN, USA

    Rekha Mankad, Elena Myasoedova & Eric L Matteson

  2. Loyola University Medical Center, Maywood, IL, USA

    Carolyn A Ball

Authors
  1. Rekha Mankad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolyn A Ball
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Myasoedova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric L Matteson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Preventive Cardio-Rheuma Clinic, Diakonhjemmet Hospital, Oslo, Oslo, Norway

    Anne Grete Semb

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mankad, R., Ball, C.A., Myasoedova, E., Matteson, E.L. (2017). Non-atherosclerotic Cardiac Manifestations of Rheumatoid Arthritis. In: Semb, A. (eds) Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis. Adis, Cham. https://doi.org/10.1007/978-3-319-26782-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26782-1_2

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-26780-7

  • Online ISBN: 978-3-319-26782-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation